Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of Warrants Issued and Outstanding with Exercise Price

Issue Date	Warrants Issued and Outstanding as of March 31, 2022
April 25, 2019 exercise price of $20.00		50,000
November 13, 2020 exercise price of $20.00		50,000
September 8, 2021 exercise price of $10.00		1,223,240
September 8, 2021 exercise price of $12.50		135,000
September 30, 2021 exercise price of $10.00		165,000
September 30, 2021 exercise price of $12.50		14,850

The following is a summary of warrants outstanding as of March 31:

	2022							2021
	Number of Warrants			Weighted Average Price		Weighted Average Remaining Life		Number of Warrants		Weighted Average Price		Weighted Average Remaining Life
Beginning of the year		1,914,850		$	10.72		4.7		100,000	$	20.00		6.1
Issuance		—		$	—		—		—		—		—
Exercised		(276,760	)	$	10.00		—		—		—		—
Ending balance		1,638,090		$	10.84		4.5		100,000	$	20.00		5.8
Warrants exercisable		1,638,090		$	10.84		4.5		100,000		20.00		5.8

Schedule of Restricted Common Shares Issued

The following is a summary of restricted shares issued as of March 31:

	2022			2021
Number of Shares Outstanding at beginning of the period		23,167			14,582
Restricted Shares Issued		47,142			14,000
Restricted Shares Vested		(10,500	)		(3,749	)
Number of Restricted Shares Outstanding at end of the period		59,809			24,833
Compensation expense	$	93,926		$	49,471

Schedule of Cash Distributions

The following is a summary of distributions to common shareholders and operating partnership unit holders for the three months ended March 31, 2022 and 2021:

Board of Directors Authorized Date	Record Date	Per Share or Per Unit Cash Distributions to Common Shareholders and Operating Partnership Unit Holders
December 10, 2021	March 15, 2022	$	0.054
December 10, 2021	February 15, 2022	$	0.054
December 10, 2021	January 15, 2022	$	0.054
February 26, 2021	March 15, 2021	$	0.325

* Our president and chairman waived his right to receive a distribution for all of these periods mentioned above.